Journal Article

Lorlatinib in a Child with ALK -Fusion–Positive High-Grade Glioma

  • Bagchi A
  • Orr B
  • Campagne O
  • et al.
New England Journal of Medicine (2021) 385(8) 761-763
DOI: 10.1056/nejmc2101264
47Citations
Citations of this article
33Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Lorlatinib Response in ALK-Fusion–Positive Glioma A child near death with an ALK-fusion–positive high-grade glioma refractory to standard treatment had a dramatic response when treatment with lorla...

Cite

CITATION STYLE

APA

Bagchi, A., Orr, B. A., Campagne, O., Dhanda, S., Nair, S., Tran, Q., … Robinson, G. W. (2021). Lorlatinib in a Child with ALK -Fusion–Positive High-Grade Glioma. New England Journal of Medicine, 385(8), 761–763. https://doi.org/10.1056/nejmc2101264

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free